117 related articles for article (PubMed ID: 12144812)
21. Cuttine edge: diabetes-associated quantitative trait locus, Idd4, is responsible for the IL-12p40 overexpression defect in nonobese diabetic (NOD) mice.
Simpson PB; Mistry MS; Maki RA; Yang W; Schwarz DA; Johnson EB; Lio FM; Alleva DG
J Immunol; 2003 Oct; 171(7):3333-7. PubMed ID: 14500624
[TBL] [Abstract][Full Text] [Related]
22. The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine experimental autoimmune encephalomyelitis.
Greve B; Vijayakrishnan L; Kubal A; Sobel RA; Peterson LB; Wicker LS; Kuchroo VK
J Immunol; 2004 Jul; 173(1):157-63. PubMed ID: 15210770
[TBL] [Abstract][Full Text] [Related]
23. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes.
Jaeckel E; Lipes MA; von Boehmer H
Nat Immunol; 2004 Oct; 5(10):1028-35. PubMed ID: 15378058
[TBL] [Abstract][Full Text] [Related]
24. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q.
Hashimoto L; Habita C; Beressi JP; Delepine M; Besse C; Cambon-Thomsen A; Deschamps I; Rotter JI; Djoulah S; James MR
Nature; 1994 Sep; 371(6493):161-4. PubMed ID: 8072544
[TBL] [Abstract][Full Text] [Related]
25. Statistical evaluation of multiple-locus linkage data in experimental species and its relevance to human studies: application to nonobese diabetic (NOD) mouse and human insulin-dependent diabetes mellitus (IDDM).
Risch N; Ghosh S; Todd JA
Am J Hum Genet; 1993 Sep; 53(3):702-14. PubMed ID: 8352278
[TBL] [Abstract][Full Text] [Related]
26. An HLA-Transgenic Mouse Model of Type 1 Diabetes That Incorporates the Reduced but Not Abolished Thymic Insulin Expression Seen in Patients.
Babad J; Ali R; Schloss J; DiLorenzo TP
J Diabetes Res; 2016; 2016():7959060. PubMed ID: 26824049
[TBL] [Abstract][Full Text] [Related]
27. Genetic and physiological association of diabetes susceptibility with raised Na+/H+ exchange activity.
Morahan G; McClive P; Huang D; Little P; Baxter A
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5898-902. PubMed ID: 8016086
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region.
Colucci F; Bergman ML; Penha-Gonçalves C; Cilio CM; Holmberg D
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8670-4. PubMed ID: 9238035
[TBL] [Abstract][Full Text] [Related]
29. Increased thymic development of regulatory T cells in NOD mice is functionally dissociated from type I diabetes susceptibility.
Tellier J; Andrianjaka A; Vicente R; Thiault N; Enault G; Garchon HJ; van Meerwijk JP; Romagnoli P
Eur J Immunol; 2013 May; 43(5):1356-62. PubMed ID: 23400928
[TBL] [Abstract][Full Text] [Related]
30. Localization of Idd11 using NOD congenic mouse strains: elimination of Slc9a1 as a candidate gene.
Brodnicki TC; McClive P; Couper S; Morahan G
Immunogenetics; 2000 Jan; 51(1):37-41. PubMed ID: 10663560
[TBL] [Abstract][Full Text] [Related]
31. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
[TBL] [Abstract][Full Text] [Related]
32. Genetic control of autoimmune diabetes in the NOD mouse.
Wicker LS; Todd JA; Peterson LB
Annu Rev Immunol; 1995; 13():179-200. PubMed ID: 7612220
[TBL] [Abstract][Full Text] [Related]
33. Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci.
Grattan M; Mi QS; Meagher C; Delovitch TL
Diabetes; 2002 Jan; 51(1):215-23. PubMed ID: 11756344
[TBL] [Abstract][Full Text] [Related]
34. Increased autoimmune diabetes in pIgR-deficient NOD mice is due to a "Hitchhiking" interval that refines the genetic effect of Idd5.4.
Simpfendorfer KR; Strugnell RA; Brodnicki TC; Wijburg OL
PLoS One; 2015; 10(4):e0121979. PubMed ID: 25835383
[TBL] [Abstract][Full Text] [Related]
35. Sex-specific effect of insulin-dependent diabetes 4 on regulation of diabetes pathogenesis in the nonobese diabetic mouse.
Ivakine EA; Fox CJ; Paterson AD; Mortin-Toth SM; Canty A; Walton DS; Aleksa K; Ito S; Danska JS
J Immunol; 2005 Jun; 174(11):7129-40. PubMed ID: 15905556
[TBL] [Abstract][Full Text] [Related]
36. Sequence analysis of Tnf as a candidate for Idd16.
Babaya N; Ikegami H; Fujisawa T; Ueda H; Nojima K; Itoi-Babaya M; Yamada K; Kawaguchi Y; Yamato E; Makino S; Ogihara T
Autoimmunity; 2002 Feb; 35(1):63-6. PubMed ID: 11908709
[TBL] [Abstract][Full Text] [Related]
37. The phenotype of lymphoid cells and thymic epithelium correlates with development of autoimmune insulitis in NOD in equilibrium with C57BL/6 allophenic chimeras.
Forsgren S; Dahl U; Söderström A; Holmberg D; Matsunaga T
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9335-9. PubMed ID: 1924397
[TBL] [Abstract][Full Text] [Related]
38. Effect of the expression of DR alpha E beta NOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse.
Yamane K; Yamamoto K; Yoshikawa Y; Sasazuki T
Clin Exp Immunol; 1996 Jan; 103(1):141-8. PubMed ID: 8565273
[TBL] [Abstract][Full Text] [Related]
39. Genetic analysis of autoimmune sialadenitis in nonobese diabetic mice: a major susceptibility region on chromosome 1.
Boulard O; Fluteau G; Eloy L; Damotte D; Bedossa P; Garchon HJ
J Immunol; 2002 Apr; 168(8):4192-201. PubMed ID: 11937580
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2.
Siegmund T; Armitage N; Wicker LS; Peterson LB; Todd JA; Lyons PA
Diabetes; 2000 Sep; 49(9):1612-6. PubMed ID: 10969850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
